1. Response to Tanezumab, as assessed by outcome measures in rheumatology-osteoarthritis research society international criteria, in patients with osteoarthritis of the knee or hip. (April 2018) Authors: Schnitzer, T.J.; Bello, A.E.; West, C.R.; Pixton, G.C.; Tive, L. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗